{"count": 3, "results": [{"_id": "9179087", "pmid": 9179087, "title": "Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.", "journal": "Can J Cardiol", "authors": ["Marcotte F", "Honos GN", "Walling AD", "Beauvais D", "Blais MJ", "Daoust C", "Lisbona A", "McCans JL"], "date": "1997-05-01T00:00:00Z", "meta_date_publication": "1997 May", "meta_volume": "13", "meta_issue": "5", "meta_pages": "479-85", "score": 50051.598, "text_hl": "The study drug was stopped in four @SPECIES_9606 @@@patients@@@ after one @SPECIES_9606 @@@patient@@@ presented with rapid @DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ and @<m>DISEASE_Angina_Pectoris</m> @DISEASE_MESH:D000787 @@@angina@@@ while three @SPECIES_9606 @@@patients@@@ were intolerant to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Marcotte F, Honos GN, Walling AD, Beauvais D, Blais MJ, Daoust C, Lisbona A, McCans JL. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol. 1997 May;13(5):479-85. PMID: 9179087", "BibTeX": "@article{9179087, title={Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function.}, author={Marcotte F and Honos GN and Walling AD and Beauvais D and Blais MJ and Daoust C and Lisbona A and McCans JL}, journal={Can J Cardiol}, volume={13}, number={5}, pages={479-85}}"}}, {"_id": "16864749", "pmid": 16864749, "title": "Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.", "journal": "Hypertension", "authors": ["Leenen FH", "Nwachuku CE", "Black HR", "Cushman WC", "Davis BR", "Simpson LM", "Alderman MH", "Atlas SA", "Basile JN", "Cuyjet AB", "Dart R", "Felicetta JV", "Grimm RH", "Haywood LJ", "Jafri SZ", "Proschan MA", "Thadani U", "Whelton PK", "Wright JT", "Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group"], "date": "2006-09-01T00:00:00Z", "doi": "10.1161/01.HYP.0000231662.77359.de", "meta_date_publication": "2006 Sep", "meta_volume": "48", "meta_issue": "3", "meta_pages": "374-84", "score": 50050.457, "text_hl": "Rates of combined @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@CVD@@@ were higher (RR=1.06, 95% CI 1.00 to 1.12) because of higher rates for @DISEASE_Stroke @DISEASE_MESH:D020521 @@@strokes@@@, @DISEASE_Peripheral_Arterial_Disease @DISEASE_MESH:D058729 @@@peripheral arterial disease@@@, and @<m>DISEASE_Angina_Pectoris</m> @DISEASE_MESH:D000787 @@@angina@@@, which were partly offset by lower rates for @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ (RR=0.87, 95% CI 0.78 to 0.96) on @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ compared with @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep;48(3):374-84. PMID: 16864749", "BibTeX": "@article{16864749, title={Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.}, author={Leenen FH and Nwachuku CE and Black HR and Cushman WC and Davis BR and Simpson LM and Alderman MH and Atlas SA and Basile JN and Cuyjet AB and Dart R and Felicetta JV and Grimm RH and Haywood LJ and Jafri SZ and Proschan MA and Thadani U and Whelton PK and Wright JT and Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group}, journal={Hypertension}, volume={48}, number={3}, pages={374-84}}"}}, {"_id": "12851621", "pmid": 12851621, "title": "Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial.", "journal": "Am Heart J", "authors": ["Latini R", "Staszewsky L", "Maggioni AP", "Marino P", "Hernandez-Bernal F", "Tognoni G", "Labarta V", "Gramenzi S", "Bianchi F", "Sarcina G", "Cremonesi G", "Nicolosi GL", "Geraci E", "Delapril Remodeling after Acute Myocardial Infarction Collaborative Group"], "date": "2003-07-01T00:00:00Z", "doi": "10.1016/S0002-8703(02)94777-0", "meta_date_publication": "2003 Jul", "meta_volume": "146", "meta_issue": "1", "meta_pages": "133", "score": 50049.395, "text_hl": "The 2 ACEIs, @CHEMICAL_delapril @CHEMICAL_MESH:C047759 @@@delapril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, appeared to be equally well tolerated.", "citations": {"NLM": "Latini R, Staszewsky L, Maggioni AP, Marino P, Hernandez-Bernal F, Tognoni G, Labarta V, Gramenzi S, Bianchi F, Sarcina G, Cremonesi G, Nicolosi GL, Geraci E, Delapril Remodeling after Acute Myocardial Infarction Collaborative Group. Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial. Am Heart J. 2003 Jul;146(1):133. PMID: 12851621", "BibTeX": "@article{12851621, title={Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the Delapril Remodeling after Acute Myocardial Infarction (DRAMI) trial.}, author={Latini R and Staszewsky L and Maggioni AP and Marino P and Hernandez-Bernal F and Tognoni G and Labarta V and Gramenzi S and Bianchi F and Sarcina G and Cremonesi G and Nicolosi GL and Geraci E and Delapril Remodeling after Acute Myocardial Infarction Collaborative Group}, journal={Am Heart J}, volume={146}, number={1}, pages={133}}"}}]}